Analytics & Formulation for biologics
With longstanding experience in biotherapeutics development, the GTP Bioways team provides expert services for the characterisation and formulation of a wide range of biologics.
Experts in analytical development for biologics
Our analytical team is uniquely proficient at developing analytical methods for the characterisation of a diversity of molecules from conventional monoclonal antibodies to complex proteins – including enzymes, growth factors, immunocytokines, virus-like particles and peptides.
Learn more about our analytical and formulation services to take the guess work out of your project
Analytics
Host cell protein
ELISA Development
Formulation
Expert services compliant with regulatory requirements
A knowledgeable team dedicated to process-specific HCP ELISA development
We offer a unique and recognised range of services, including research and testing to determine the feasibility of your process, as well as the development and manufacturing of ready-to-use ELISA kits.
Formulation development
Our formulation development team uses their in-depth knowledge of the performance and interactivity of commonly-used buffers and excipients to design a tailored approach for each molecule.
Our formulation service is supported by our state-of-the-art analytical laboratory.
A comprehensive range of analytical services
The routine activities of our analytical and quality control teams include:
- Method development and validation
- Analytical support for USP and DSP
- DS and DP release for all clinical phases and up to commercialisation
- Stability studies
- Raw material testing and environmental monitoring
Webinar
HCP Risk Management
Vincent Rivera, founder and director at GTP Immuno (part of GTP Bioways) is sharing his great experience regarding HCP (host cell proteins) and biocontaminants risk management.
Are you looking for a CDMO partner to move your biotherapeutics to clinic?
Connect with our team and we will get back to you shortly.
